Because the metrics on a look through scenario with BPH are very favourable at the current price, so shareholders would be mad not to take up their entitlement, plus 62 Capital would make sure that they at least get the minimum to get re-listed.
I mean why do you care anyway?
- Forums
- ASX - By Stock
- MMR
- Ann: Supplementary Prospectus
Ann: Supplementary Prospectus, page-25
-
-
- There are more pages in this discussion • 221 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MMR (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.236M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MMR (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online